ArticlePloS one2022
Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
Sebastian A Omenai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it